Rheumatoid Arthritis (RA) is a chronic autoimmune disorder characterized by progressive joint inflammation, pain, and disability. Early diagnosis and personalized management remain a major challenge, as conventional approaches often rely on generalized pharmacological interventions with potential long-term side effects.

In Unani medicine, the concept of Mizaj (temperament) plays a central role in understanding individual susceptibility to disease, prognosis, and treatment planning. Assessing Mizaj could provide valuable insights into early detection, risk stratification, and personalized therapeutic strategies for patients with RA.